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Alloplastic temporomandibular joint replacement (TMJ TJR) presents unique problems due
to  the integral and multifaceted roles this joint plays within the stomatognathic system to
establish and maintain appropriate mandibular function and form. The TMJ  not only acts as
a  secondary mandibular growth center pre-puberty, but is also crucial in maintaining proper
mastication, speech, airway support and deglutition. Further, these essential life functions
place the TMJ under more cyclical loading and unloading than any other body joint over a
lifetime. Therefore, when TMJ TJR is indicated the device chosen must be able to provide
long-term mandibular function and form outcomes.
End-stage TMJ pathology accompanied by physiological function and anatomical form
distortions dictates the need for replacement. Due to the complex nature of joint related
masticatory muscle functional and anatomical associations, it is unreasonable to expect an
autogenous reconstructed TMJ or an alloplastic replaced TMJ can be returned to “normal”
pre-morbid function. Therefore, as is understood with any orthopaedic joint replacement,
patient and surgeon must agree and accept that there will always be some functional dis-
ability involved with any reconstructed or replaced TMJ.
Further, in the multiply operated, anatomically distorted patients, chronic neuropathic
centrally mediated pain will always be a major component of their disability.1 Therefore, it
is  imperative that surgeon and patient understand that the primary goal of any TMJ TJR is
the  restoration mandibular function and form and that any pain relief must be considered
of  only secondary beneﬁt.
This paper will discuss the role of custom TMJ TJR devices have in the management of
severe and debilitating TMJ disorders.
© 2012 SECOM. Published by Elsevier España, S.L. All rights reserved.
Papel  de  la  prótesis  hecha  a  medida  a  medida  para  la  sustitución
de  la  articulación  temporomandibularalabras clave:
ustitución de la articulación
emporomandibular
r  e  s  u  m  e  n
La sustitución aloplástica de la articulación temporomandibular plantea problemas exclu-
sivos debido al papel esencial y polifacético que esta articulación desempen˜a en el sistema
estomatognático para establecer y mantener la función y forma mandibular apropiadas. La
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articulación temporomandibular no sólo actúa como un centro prepuberal del crecimiento
mandibular secundario sino que también es decisiva en el mantenimiento de la masticación,
el  habla, soporte de las vías respiratorias y deglución apropiadas. Además, estas funciones
vitales esenciales producen en la articulación una mayor carga y descarga cíclicas que en
cualquier otra articulación corporal durante la vida. Por consiguiente, cuando está indi-
cada  una sustitución aloplástica de la articulación, el dispositivo elegido debe ser capaz de
proporcionar desenlaces favorables de la funcionalidad y forma mandibular a largo plazo.
La  patología terminal de la articulación, acompan˜ada de distorsiones de la funcionali-
dad  ﬁsiológica y de la forma anatómica, dicta la necesidad de su sustitución. Debido a la
naturaleza compleja de las asociaciones funcionales y anatómicas de la articulación rela-
cionadas con los músculos de la masticación, no es razonable esperar que la reconstrucción
autóloga de la articulación o una sustitución aloplástica puedan restablecer la función pre-
mórbida «normal». Por consiguiente, como se entiende con cualquier sustitución ortopédica
de  una articulación, el cirujano y el paciente deben estar de acuerdo (y aceptar) que, en la
reconstrucción o sustitución de la articulación, siempre estará presente cierto grado de
discapacidad funcional.
Por otra parte, en pacientes con una distorsión anatómica por múltiples intervenciones, el
dolor neuropático crónico, mediado centralmente, siempre será un importante componente
de  su discapacidad1. Por esta razón, es indispensable que el cirujano y el paciente entiendan
que el objetivo primario de cualquier sustitución de la articulación es el restablecimiento
de la funcionalidad y forma mandibular y que el alivio del dolor debe considerarse tan sólo
un  beneﬁcio secundario.
En este artículo, se describirá el papel que desempen˜an los dispositivos hechos a medida
para la sustitución de la articulación temporomandibular en el manejo de las enfermedades
graves y debilitantes de la articulación.
OM. P© 2012 SEC
Introduction
Prior to the 1980s, the primarily reasons for TMJ recon-
struction were the management of ankylosis, developmental
maxillofacial deformities, severe inﬂammatory joint disease,
or reconstruction after ablative tumor surgery or trauma.
Thereafter, along with the aforementioned form and func-
tion challenges, there arose a group of patients requiring TMJ
replacement who had previously undergone multiple unsuc-
cessful invasive TMJ surgical procedures.2
As more  of these complex patients presented, many  were
left with anatomically distorted and functionless joints, the
result of the material failure of interpositional Proplast –
Teﬂon (Vitek, Houston, TX) and/or Silastic (Dow-Corning-
Wright, Arlington, TX). Interested reconstructive surgeons
began developing goals to achieve physiologically reasonable,
biologically rational and technically achievable outcomes not
just considering form and functional requirements.
Consequently, based on decades of orthopaedic joint
replacement experience, the following goals for TMJ  replace-
ment were developed and accepted3:
(1) Improvement mandibular function and form
(2) Reduction of further suffering and disability
(3) Containment of excessive treatment and cost
(4) Prevention of further morbidityIndications  for  TMJ  TJR
The following indications for custom TMJ TJR were then
established4:ublicado por Elsevier España, S.L. Todos los derechos reservados.
Inﬂammatory  arthritis  involving  the  TMJ,  not  responsive
to other  modalities  of  treatment
Since inﬂammatory arthritis involves a local, synovially
mediated, destructive systemic disease process and complete
synovectomy is not possible, the orthopaedic literature opts
for alloplastic total joint replacement because the outcomes
are very predictable.5
TMJ TJR in inﬂammatory disease has been discussed at
length.6–19 These authors all agree that when the mandibular
condyle is extensively damaged, degenerated or missing, as
often seen in inﬂammatory arthritic conditions, TMJ  TJR is a
safe and effective approach to achieving optimal functional,
esthetic and symptomatic improvement outcomes. Freitas16
reported on 12 arthritic non-growing patients (24 joints)
requiring TMJ TJR. Six were managed with autogenous bone
grafts and six with custom TMJ  prostheses. The authors
reported that based on the criteria established for the study,
the custom TMJ TJR patients had statistically signiﬁcant
better subjective and objective outcomes than did those
reconstructed with autogenous bone. In light of these results
and the fact that the alloplastic TMJ TJR avoided the need for
another operative site avoided potential morbidity, decreased
operating room time and allowed for simultaneous mandibu-
lar advancement with predictable long-term results, they
concluded that custom TMJ TJR was superior to autogenous
bone grafting in arthritic TMJ disease. Reports indicating
the long-term stability of custom TMJ  TJR in patients with
low-inﬂammatory or high-inﬂammatory arthritic conditions
followed.17–19
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ecurrent  ﬁbrosis  and/or  bony  ankylosis  not  responsive  to
ther  modalities  of  treatment
he traditional management of TMJ  complete bony ankylosis
nd re-ankylosis has been gap arthroplasty with autoge-
ous soft or hard tissue graft reconstruction, or alloplastic
emiarthroplasty replacement. While autogenous grafting
echniques can provide mandibular form, mandibular func-
ion is typically be delayed. Autogenous graft mobility during
ealing will compromise the graft’s incorporation into the host
one and soft tissue environment or compromise the graft’s
ascent blood supply.2 It has been demonstrated that early
andibular mobility leads to graft/host interface failure.20
For the patient with re-ankylosis, placing autogenous bone
nto an area where reactive or heterotopic bone is form-
ng intuitively makes no sense. Orthopaedic surgeons opt
or total alloplastic joint reconstruction in similar situations
n other joints.21 Therefore, in light of biologic factors and
he orthopaedic experience, TJR should be considered the
anagement option of choice for TMJ  ankylosis and re-
nkylosis.2,4,8
Custom TMJ  TJR device components are designed and man-
factured for each speciﬁc case and clinical situation from
 protocol CT scan generated stereolithographic model with
eported mean dimensional accuracy of 97.9%.22 Therefore, in
nkylosis or re-ankylosis cases, the surgeon must in a ﬁrst
tage procedure free the ankylosis by creating an appropri-
te gap (2–2.5 cm); place an anatomical spacer to prevent the
eformation of tissue and/or bone23; and place the patient in
axillomandibular ﬁxation (MMF)  to prevent movement  of
he spacer or change in occlusion before protocol CT scan is
ade. The device is then designed and manufactured over the
ext 6 weeks.
During a second stage procedure, the spacer is removed,
ustom TMJ  TJR fossa and ramus components are ﬁx-
ted, autogenous abdominal fat graft is placed around the
rticulation,24,25 and the patient begins immediate active
ost-operative physical therapy.
Pearce et al.26 described the use of pre-operatively devel-
ped templates to obviate the 2 staged protocol described
bove. However, it remains the author’s opinion that to achieve
he beneﬁt of longevity provided by the custom TMJ TJR
evice in ankylosis cases, the best component-to-bone inter-
ace of the components will be achieved and assured by using
he 2 staged approach. The concern about maintaining MMF
etween stages is moot in ankylosis since these patients from
he start could not open their mouths before the ﬁrst stage of
his procedure.
ailed  tissue  grafts  (bone  and  soft  tissue)
utogenous tissue grafting success requires that the host site
ave a rich vascular bed. Unfortunately, the scar tissue always
ncountered in the multiply operated patient and many
nd-stage disease TMJ  cases does not provide an environ-
ent conducive to the predictable outcomes for free, or evenhe occasional vascularized, autogenous tissue graft. Marx
eported that capillaries can penetrate a maximum thickness
f 180–220  of tissue, whereas, scar tissue surrounding pre-
iously operated bone averages 440  in thickness.2 This mayf a c . 2 0 1 3;3 5(1):1–10 3
account for the clinical observation that free autogenous tis-
sue TMJ reconstructions using cartilage, costochondral and
sternoclavicular grafts often fail in cases of multiply operated
patients or those with extreme anatomical architectural dis-
crepancies resulting from end-stage pathology.12,13 Therefore,
as with the ankylosis and re-ankylosis cases, custom TMJ  TJR
should be considered in the management of cases where failed
tissue grafts are encountered.
Failed  alloplastic  joint  reconstruction
Due to the osteolysis that occurs around past failed and par-
ticulated TMJ alloplastic materials and the resultant host bone
architectural discrepancies created, it is difﬁcult to adapt and
stably ﬁxate autogenous tissue or stock TMJ  TJR device com-
ponents to the distorted anatomical host bone of either the
temporal glenoid fossa or mandibular ramus.
Further, the foreign body giant cell reactions which accom-
pany failed or failing devices provide a poor environment for
successful outcomes with an autogenous graft. Henry and
Wolford conﬁrm this as they reported that custom TMJ  TJR
provided more  consistently predictable outcomes than did
reconstruction with autogenous tissue in such cases.27
Loss  of  vertical  mandibular  height  and/or  occlusal
relationship  due  to  bony  resorption,  trauma,
developmental  abnormalities,  or  pathologic  lesions
Loss of posterior mandibular vertical dimension due to devel-
opmental abnormalities, pathology, or traumatic injury all
result in inconsistencies in both mandibular function and
form. The later manifested as either an anterior (bilateral)
or lateral (unilateral) apertognathia. After proper diagnosis
of the etiology, correction of these maxillomandibular form
and functional disorders should be directed to the site of the
pathology – the TMJ.28
Custom TMJ TJR rather than osteotomy or autogenous tis-
sue reconstruction or stock TMJ TJR should be considered in
light of these the nature of the pathology, the patient’s prior
local surgical history and the state of the host bone archi-
tecture in these complex cases. Westermark et al. reported
successfully managing large, complex mandibular defects
involving the TMJ using a patient-ﬁtted (custom) TMJ  TJR
system.29
Relative  contraindications  to  alloplastic  TMJ  TJR
The literature considers the following to be relative contraindi-
cations to alloplastic TMJ TJR4:
Age  of  the  patient
Since alloplastic TMJ TJR devices themselves have no inherent
growth potential, the beneﬁts of their use in growing patients
over autogenous tissue must be considered carefully before
their utilization in such cases. However, recent literature sug-
gests that further investigation into the use of custom TMJ TJR
in the growing patient may be justiﬁed in cases of re-ankylosis
 x i l o4  r e v e s p c i r o r a l m a
following unpredictable growth or failed autogenous tissue
reconstruction.30
Mental  status  and  competency  of  the  patient
Is the patient psychologically prepared to cope with the per-
manent loss of a body part with the understanding that
revision and/or replacement surgery in the future may be
required? Does the patient have unrealistic expectations of
complete relief of pain and normal jaw function after TMJ  TJR?
Is the patient willing and/or able to do the post-implantation
physical therapy required to obtain maximum functional ben-
eﬁt from the procedure? Many  of the multiply operated,
functionless TMJ  patients require pre-replacement referral to
psychological and/or pain, and/or drug addiction counseling
programs for them to accept the limitations of TMJ  TJR to
resolve their chronic pain/drug dependence issues.
Uncontrolled  systemic  disease
As with any form of an alloplastic implant – dental,
orthopaedic or TMJ  – once the potentially compromising sys-
temic disease process has been controlled and the risk/beneﬁt
ratio is deﬁned for the individual patient, TMJ  TJR can proceed
and should be monitored closely.
Active  infection  at  the  implantation  site
Introduction of any alloplastic device into an infected or con-
taminated area can lead to failure of the device to stabilize
in the host environment, ultimately resulting in its failure
and loss. While this is true of all alloplasts, it is of particular
concern with implants that have a planned long-term func-
tion under loading, such as with dental implants and TMJ TJR
devices.
Documented  allergy  to  the  materials  that  are  used  in  the
devices  to  be  implanted
Documented allergy to the biomaterials commonly used to
manufacture TMJ  TJR devices – commercially pure titanium,
titanium alloy, cobalt–chrome–molybdenum alloy, ultra-high
molecular weight polyethylene – is rare. Although 12–15%
of the population can be sensitive to the nickel alloy
in cobalt–chrome–molybdenum TJR components, far fewer
reports of such allergic reactions have been reported in the
orthopaedic literature.21 Patients with documented allergy to
the component metals should not be exposed to that material
in any new implanted device.
Discussion
There are two types of alloplastic TMJ  TJR devices available,
stock or “off the shelf” devices which the surgeon must make
ﬁt and custom TMJ  TJR devices which are made to ﬁt.In the only report in the refereed oral and maxillofacial
surgery literature that compares stock and custom TMJ TJR
systems, the authors concluded that patients implanted with
the study custom TMJ  TJR had statistically signiﬁcant better f a c . 2 0 1 3;3  5(1):1–10
outcomes in both the subjective and objective domains than
did those implanted with the study stock TMJ  TJR devices.31
Why  use  a  custom  TMJ  TJR  device?
Utilizing criteria established for successful TJR by
orthopaedists, an argument can be developed for the
superiority of custom TMJ  TJR devices32:
The  components  of  any  TJR  system  must  be  stabile  in  situ
from implantation
All implanted alloplastic devices, be they dental implants,
orthopaedic or TMJ TJR devices, depend on the principle of
osseointegration of the ﬁxation components (screws, in the
case of orthopaedic and TMJ TJR devices) for their ultimate
stability and longevity. Osseointegration implies the direct
incorporation of the ﬁxation components with the host bone
without the preliminary phase of ﬁbrous tissue ingrowth.33
The requirements for osseointegration are essentially the
same as for primary fracture healing – the transmission of
forces from the implant to the bone and vice versa must occur
without relative motion or without intermittent loading.33
The most important principle in TMJ TJR surgery must be
the stability of the device components at implantation. In
orthopaedic surgery, some TJR devices can be initially stabi-
lized by press-ﬁtting or cementation into the cancellous shaft
of the host long bone. However, the anatomy of the TMJ  itself,
mandibular ramus and the temporal glenoid fossa do not
allow those options. Therefore, initial ﬁxation and stabiliza-
tion of all present TMJ TJR device fossa and ramus/condyle
components must be provided by screws (Fig. 1).
Compounding the stability and ﬁxation issues is the fact
that most patients presenting with indications for TMJ  TJR
have distorted anatomy, the result of either numerous failed
prior surgical interventions, material or device failures, or by
primary or secondary end-stage joint pathology (i.e., rheuma-
toid arthritis). This makes it extremely difﬁcult to effect a
long-term stable reconstruction with stock TMJ  TJR device
components.
All stock TMJ TJR devices require the surgeon to “make the
components ﬁt”. To do this these devices commonly require
precious host bone be removed at implantation, or often
one or both components must be bent to ﬁt, shimmed with
bone or alloplastic cement in order to develop some reason-
able component-to-host bone interface or “ﬁt”. Such maneu-
vers can lead to component material fatigue overload which
may promote early material failure with functional loading.
More concerning is that any of these alterations that result
in inadequate component-to-host bone contact can result in
micromotion of the stock device components which may lead
to suboptimal screw ﬁxation osseointegration. Micromotion
leads to the formation of a ﬁbrous connective tissue interface
between the altered TMJ TJR component and the host bone
resulting in early loosening of the screw ﬁxation. This can
lead to component mobility and potential early catastrophic
or certain future premature device failure (Fig. 2).
Custom TMJ TJR devices are “made to ﬁt”. The components
can be designed and manufactured to conform and manage
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Fig. 1 – Custom TMJ  TJR fossa and ramal components screw ﬁxated (TMJ Concepts, Ventura, CA). Commercially pure
titanium (CP Ti) mesh fossa backing for UHMWPE articulating surface with posterior stop; wrought alloyed titanium
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ny unique anatomical situation (Fig. 3). At implantation, nei-
her the components nor the host bone require alteration,
ugmentation or supplementation to achieve initial overall
omponent-to-host bone stability maximizing the prospect
or ﬁxation screw osseointegration. This results in screw ﬁx-
tion that secures the custom TMJ  TJR device components to
he host bone, mitigating the potential for micromotion and is
ig. 2 – Failed bilateral metal-on-metal stock TMJ  TJR device
-year post-implantation. Note poor adaptation of both
amal components, loose screws and fractured left fossa.g condylar head.
responsible for the long-term reported stability and function
of custom TMJ replacement devices.34–37
The  materials  from  which  patient-ﬁtted  (custom)  TMJ  TJR
devices are  manufactured  are  biocompatible  and  able  to
withstand  the  forces  of  mandibular  functionIn 1960, Sir John Charnley reported the use of a total
alloplastic prosthetic hip replacement system utilizing
an ultra-high molecular weight polyethylene (UHMWPE)
Fig. 3 – Custom TMJ  TJR components (TMJ Concepts,
Ventura CA) demonstrating the variability of anatomical
architecture resulting in different component designs
within the same patient.
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Fig. 4 – Lack of posterior fossa component stop resulting in
posterior displacement of condylar head of a stock
metal-on-all UHMWPE TMJ  TJR device after bi-maxillary6  r e v e s p c i r o r a l m a
polymer acetabular cup articulating with a stainless steel
femoral head component, both of which were cemented
to place with polymethylmethacrylate.38 Modiﬁcations of
this device utilizing titanium, titanium alloy and cobalt-
chromium-molybdenum have become the gold standard for
low friction orthopaedic TJR surgery to date.21
The custom TMJ  TJR device with the most published stud-
ies in refereed literature is manufactured using commercially
pure titanium (CP Ti) as the fossa backing for UHMWPE artic-
ulating surface; wrought alloyed titanium (Ti–6Al–4V) for the
ramus component and wrought Co–Cr–Mb for the articulating
condylar head (Fig. 1).
TJR  devices  must  be  designed  to  withstand  the  loads
delivered  over  the  full  range  of  function  for  each  patient’s
speciﬁc  clinical  and  anatomical  situation
The advantage a custom TMJ  TJR device affords, besides sta-
bility of ﬁt at implantation and composition materials, is that
the device components are speciﬁcally designed to manage
the loads posed in any clinical situation.
Stock TMJ  TJR systems in which there are multiple “make
ﬁt” choices either thin cast Co–Cr fossa or all UHMWPE fossa
components as well as cast Cr–Co ramus/condyle compo-
nents can pose multiple pitfalls.Metal-on-metal geometry to
be successful in orthopaedic TJR can only be applied to a TJR
hip where tightly constrained radial clearances of less than
200 m between the metal acetabular cup and metal femoral
head are mandatory or wear related metal particulation will
lead to metalosis, osteolysis, loosening, and micromotion
leading to device failure.39–42
Metal-on-metal devices would never be designed for knee
TJR because of that joint’s functional anatomy is not con-
strained as is the hip joint. The same should be true of
the TMJ,  whose functional anatomy is also not constrained,
even after TJR. Stresses and strains directly or eccentrically
vectored against an incomplete or inadequate component-to-
bone interface or unstable thin cast Co–Cr fossa by the metal
condylar head of a stock TMJ  TJR system will lead to micro-
motion, component screw loosening and/or fossa component
thin cast metal fatigue and fracture (Fig. 2).
Stock TMJ  TJR devices in which a UHMWPE ﬂange is utilized
to ﬁxate the fossa component with screws to the temporal
bone and zygomatic arch offers the potential for problems
that can lead to loosening of the stock fossa ﬁxation screws,
increased micromotion under load and eventual failure of the
component and the device.
Hallab43 enumerated the reasons why an un-backed all-
UHMWPE fossa component is not favored in orthopaedics,
especially when placed against host bone:
1) Increased back-side wear (component-to-host bone) under
function
2) Poor surface for bone ﬁxation (hydrophobic UHMWPE vs.
hydrophilic bone)
3) Decreased bone remodeling on surface of the UHMWPE
4) No macro-texturing to enhance short and long-term bone
attachment strengthorthognathic surgery.
5) Can lead to increased potential for bioﬁlm infection (due to
decreased cell attachment)
6) Increased chance of “cold ﬂow” and UHMWPE fracture.
7) Less control over host bone side implant orientation due to
greater likelihood of osteolysis on the host bone side over
time.
8) Poor surface for cementing and will likely results in high
wear and micromotion.
Lastly, since all present stock and a metal-on-metal cus-
tom TMJ TJR fossa component do not have a posterior stop,
the potential for posterior dislocation of the device condy-
lar head exists. If not perfectly aligned in the center of the
stock fossa both medio-lateral and antero-poterior, poste-
rior displacement of these condylar heads can impinge on
the auditory canal resulting in pain, malocclusion or infec-
tion should a pressure related perforation of the cartilaginous
auditory canal occur. This should be of particular concern
when using any TMJ TJR device that does not have a poste-
rior fossa component stop for orthognathic cases while setting
the condyle into “centric” during mandibular procedures, and
especially in combination with counterclockwise mandibular
rotation procedures (Fig. 4). Custom TMJ  TJR fossa components
are designed and manufactured with fossa component poste-
rior stops to accommodate such situations.
Outcome data from custom TMJ  TJR devices reveal few
device failures to date attributable to the inability of these
devices to withstand standard loads when the appropriate
34–37geometry and materials are used. For example, the cen-
ter of rotation of the condyle of a patient-ﬁtted (custom) TMJ
TJR device can be moved vertically to accommodate closure of
the open bite deformity seen in the rheumatoid patient16–19;
r e v e s p c i r o r a l m a x i l o 
Fig. 5 – Custom TMJ  TJR device (TMJ Concepts, Ventura CA)
designed to manage both fossa and mandibular defects
after ablative surgery.
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Potential  adverse  outcomesCourtesy of Dr. GR Fisher, New Orleans, LA).
he ramus component can be shaped to accommodate the
mount of host mandibular bone available. This ability to vary
he design to deal with the available anatomy leads to a more
redictable result under the expected loads delivered in each
omplex situation27 (Fig. 5).
Custom TMJ  TJR devices can be designed to provide maxi-
um screw ﬁxation for initial stability by avoiding the inferior
lveolar neurovascular bundle thereby eliminating the poten-
ial damage to this structure during screw placement. Also,
ecause the components are custom made, the proper screw
ength can be pre-determined and prescribed for the surgeon
liminating the time consuming and often frustrating intra-
perative “screw hole probing” in an attempt to determine
roper bi-cortical ﬁxation screw lengths. More importantly,
nowing the proper screw lengths prevents the use of screws
hat are too long, the medial tips of which can irritate
he temporalis and/or the medial pterygoid muscle during
andibular function causing post-implantation complaints of
ost-implantation functional muscular pain.
he  implantation  surgery  must  be  performed  for  the
roper  indications  and  aseptically
s with any management option, outcomes are only pre-
ictable when what is done is done for the right reason, at
he right time, for the right patient, the right way, and with
he right device.Schmalzried and Brown39 report that the major causes of
rthopaedic TJR failures are the result of surgical technique
r limitations of the TJR device to be able to deal with thef a c . 2 0 1 3;3 5(1):1–10 7
anatomical situation presented for replacement. The utiliza-
tion of a patient-ﬁtted (custom) TMJ TJR device would mitigate
both issues.40
Questions  and  concerns
The following issues are often raised concerning custom TMJ
TJR devices and require further clariﬁcation and discussion:
Custom  TMJ  TJR  devices  are  expensive
First, TMJ TJR devices are thought to be more  costly than
autogenous tissue. Consider the extended surgical time, per-
sonnel and resources required to complete an autogenous TMJ
reconstruction. Add to that the potential for increased mor-
bidity associated with harvesting autogenous tissue and the
increased length of hospital stay should donor site complica-
tions occur. Compare that to TMJ  TJR for the same case. The
cost of the later in time, personnel would be far less overall and
since there is no secondary donor site surgery, the potential
for such complications are negligible.
Secondly, custom TMJ TJR devices, since they are “made to
ﬁt,” require less surgical time than do stock devices that the
surgeon has to “make ﬁt”. Also, depending often on location
and factors often out of the control of the manufacturer, cus-
tom TMJ TJR devices are generally equal or slightly less in price
than stock devices.
Material  wear  and  long-term  stability  and  survivability  of
TMJ TJR  devices
There is no argument that because TMJ TJR is a biomechani-
cal rather than a biological solution to severe, end-stage TMJ
pathology, future for revision surgery to remove scar tissue
from the articulating components of the implant or even
replacement of the implant over time due to material wear
and/or failure may be required.40
However, material wear and long-term stability and surviv-
ability of custom TMJ TJR devices concerns are be mitigated
by the use of proper biomaterials and design conﬁgurations to
decrease material wear and increase device longevity under
functional loading as described above.
Post-operative  physical  therapy  issues
Since the components of a custom TMJ  TJR device interface
so well with the host bone and the ﬁxation is stable from the
time of implantation of the components, mandibular function
can begin immediately after implantation. This is considered
an essential component of rehabilitation in orthopaedic TJR
because muscle function has been compromised over time in
such cases. Salter44 in his work on Continuous Passive Motion
(CPM) after orthopaedic joint surgery has shown the impor-
tance of this concept to the long-term functional results of
joint surgery.Just as with any surgical procedure, adverse outcomes or com-
plications may occur during or following implantation of any
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TMJ  TJR device requiring further management. Complications
may be related to or inﬂuenced by the patient’s previous sur-
gical history or prior medical conditions. The most common
complications seen with custom TMJ  TJR devices include but
are not limited to:
Continued  or  increased  pain  levels  or  worsening  of  other
present  TMJ  symptoms
It has been reported that as the number of prior TMJ  surgeries
increases, the lower the subjective outcomes improvement
measures.27,34–37,45 However, objective outcomes and quality
of life measures are reported improved in long-term follow-
up.37 There is also a report of similar subjective, objective and
quality of life ﬁndings in patients previously exposed to failed
alloplastic materials (Proplast-Teﬂon and silicone rubber).36
Further, the presence of comorbid conditions in patients
with temporomandibular joint disorders (TMD) also may
explain why 50% of patients seeking care for TMD  pain, some
of whom were multiply operated and/or exposed to failed
materials or devices, still report experiencing pain ﬁve years
later, and 20% of patients experience long-term disability from
chronic pain.1,46
Infection
Fortunately post-implantation TMJ  TJR infections are rare.
When they occur, they are typically superﬁcial and are
resolved simply using appropriate antibiotic and minor sur-
gical management.47 However, the orthopaedic literature
reports a 1–2% incidence of bioﬁlm infections in orthopaedic
implants.48,49 Management of bioﬁlm infections of total joint
devices involves removal and remake/repassivation of the
device components, placement of an appropriate antibiotic
spacer in the area of the device, long-term antibiotic manage-
ment and reimplantation of the new device once all signs of
infection have resolved.50
Levent et al. developed a prospective study to examine
the signiﬁcance of 5 variables commonly associated with
the potential for surgical site infections (SSI) after knee
TJR: (1) classic risk-factors (e.g. diabetes, rheumatoid dis-
ease); (2) incomplete pre-operative skin preparation; (3)
Methicillin resistant Staphylococcus aureus (MRSA) positive
patient; (4) peri-operative antibiotic usage; (5) duration of
surgery in 364 consecutive patients. After a 1 year median
follow-up, they report a 1.4% SSI rate and of the 5 variables
only peri-operative antibiotic usage and duration of surgery
demonstrated signiﬁcance.51
Since custom TMJ  TJR components are “made to ﬁt” manip-
ulation and implantation time will be less than stock TMJ TJR
components that the surgeon must “make ﬁt” thereby poten-
tially lessening the potential for post implantation infection.
Heterotopic  bone  formation
Heterotopic bone formation is the presence of bone in soft
tissue surrounding an alloplastic joint replacement where
bone normally does not exist52 and leads to decreased
joint mobility and pain. Imaging is used to distinguish
it from other diagnostic possibilities. As treatment or f a c . 2 0 1 3;3  5(1):1–10
prophylaxis, either a non-steroidal anti-inﬂammatory drug,
such as indomethacin,53 a diphosphonate, such as ethane-1-
hydroxy-1, 1-diphosphate,54 or local radiation therapy55 have
recommended. Surgical resection is used to preserve joint
mobility; however, heterotopic bone formation is likely to
recur and possibly progress, therefore it is recommended that
an autogenous fat graft be packed around the articulation of
TMJ replacement devices to decrease this potential.24,25
Conclusion
The modern practice of orthopaedic surgery would be impossi-
ble without the availability of alloplastic TJR devices; therefore
TMJ TJR devices should likewise have a deﬁnite place in
the armamentarium of the oral and maxillofacial reconstruc-
tive surgeon for the management of the severely degenerated,
anatomically distorted, functionless TMJ patient. As has been
well documented in the orthopaedic and TMJ  literature, the
potential for an increase in the quality of life these patients
gain post TJR is an important consideration.
Custom TMJ TJR devices, because of their design, materi-
als from which they are manufactured, their inherent stability
appear to provide improved long-term successful outcomes
for patients with end-stage anatomical TMJ disease.
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